Aurion Biotech

2022 Healthcare Raised $120,000,000
Industry
Healthcare
Stage
Raised
$120,000,000

Company Overview

Aurion Biotech, a biotechnology company in the clinical stage, is dedicated to developing a groundbreaking platform of advanced therapies aimed at curing blindness. Our primary focus lies in addressing corneal endothelial disease, for which we have developed one of the pioneering cell therapies that has undergone successful clinical validation. Our mission is to revolutionize corneal care through transformative treatments.

Pitch Deck

Market Opportunity

Discover the market opportunity in the Healthcare industry. Learn about market size, growth potential, and competitive landscape.

Explore Market Research →

Similar Companies

View pitch decks from other companies in the Healthcare industry.

View Similar Pitch Decks →

Resources & Tips

Pitch Deck Best Practices

Learn how to create an effective pitch deck that resonates with investors.

Read Guide →

Fundraising Strategy

Get insights on fundraising strategies for startups.

Learn More →

Find Investors

Connect with investors interested in Healthcare startups.

Browse Investors →